Literature DB >> 6787994

Proteinuria in rheumatoid arthritis--drug-induced or amyloid?

B E Bourke, D F Woodrow, J T Scott.   

Abstract

Over a 5-year period 325 patients with rheumatoid arthritis received treatment with gold (162) or D-penicillamine (163). Thirty-eight (11.7%) developed proteinuria, which persisted in 10 patients; renal biopsies in these 10 patients revealed 6 cases of amyloid disease. These 6 cases illustrate the importance of investigation of rheumatoid patients developing proteinuria even when they are receiving potentially nephrotoxic drugs.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6787994      PMCID： PMC1000755          DOI： 10.1136/ard.40.3.240

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  8 in total

1.  AMYLOIDOSIS IN RHEUMATOID ARTHRITIS INVESTIGATED BY MEANS OF RECTAL BIOPSY.

Authors:  G ARAPAKIS; C R TRIBE
Journal:  Ann Rheum Dis       Date:  1963-07       Impact factor: 19.103

2.  Regression of amyloidosis secondary to rheumatoid arthritis.

Authors:  R A PARKINS; E G BYWATERS
Journal:  Br Med J       Date:  1959-02-28

3.  Amyloidosis in rheumatoid arthritis.

Authors:  G A MISSEN; J D TAYLOR
Journal:  J Pathol Bacteriol       Date:  1956-01

4.  A new method for the diagnosis of systemic amyloidosis.

Authors:  P Westermark; B Stenkvist
Journal:  Arch Intern Med       Date:  1973-10

5.  Penicillamine in the treatment of rheumatoid arthritis.

Authors:  E C Huskisson; F D Hart
Journal:  Ann Rheum Dis       Date:  1972-09       Impact factor: 19.103

6.  Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.

Authors:  P A Bacon; C R Tribe; J C Mackenzie; J Verrier-Jones; R H Cumming; B Amer
Journal:  Q J Med       Date:  1976-10

7.  Difficulties in the use of D-penicillamine in the treatment of rheumatoid arthritis.

Authors:  A Stockman; D Richter; D Barraclough; K D Muirden; I Macdonald; P Kincaid-Smith
Journal:  Aust N Z J Med       Date:  1979-10

8.  Post meningococcal acute glomerular nephritis.

Authors:  D J Rainford; D F Woodrow; J C Sloper; H E de Wardener; I Griffiths
Journal:  Clin Nephrol       Date:  1978-06       Impact factor: 0.975
  8 in total
  4 in total

1.  A prospective study of renal disease in patients with early rheumatoid arthritis.

Authors:  Y Koseki; C Terai; M Moriguchi; M Uesato; N Kamatani
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

2.  Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis.

Authors:  M Laakso; O Mutru; H Isomäki; K Koota
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

3.  The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis.

Authors:  Piotr Wiland; Renata Wojtala; John Goodacre; Jacek Szechinski
Journal:  Clin Rheumatol       Date:  2004-02-26       Impact factor: 2.980

Review 4.  Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs.

Authors:  William F C Rigby; Kathy Lampl; Jason M Low; Daniel E Furst
Journal:  Int J Rheumatol       Date:  2017-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.